CervoMed Inc.
CRVO | NASDAQ
$2.43
+$0.02 (+0.83%)
Sep 22, 2026, 11:00 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -2.65 | -1.16 | -9.30 | -0.68 | -1.26 | -2.67 |
PEG Ratio | -0.06 | -0.01 | 0.10 | 0.02 | 0.07 | 0.03 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 3.92 | 0.48 | 2.75 | -0.44 | 0.87 | 1.74 |
P/FCF Ratio | -3.05 | -1.14 | -2.73 | -1.53 | -2.09 | -3.18 |
P/OCF Ratio | -3.05 | -1.14 | -2.73 | -1.53 | -2.09 | -3.18 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | -1.38 | n/a | 0.01 |
Quick Ratio | 4.84 | 11.11 | 3.84 | 0.32 | 12.92 | 7.71 |
Current Ratio | 4.84 | 11.11 | 3.84 | 0.32 | 12.92 | 7.71 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | -5.92K | n/a | n/a |
Return on Equity | -147.98% | -41.56% | -29.44% | 64.49% | -69.02% | -57.16% |
Return on Assets | -115.24% | -37.81% | -21.78% | -139.57% | -63.68% | -51.15% |
Return on Invested Capital | -150.96% | -46.49% | -105.91% | -101.74% | -69.41% | -56.24% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove CRVO